GSFC Q4 Results: Higher expenses weigh on margins, profitability despite 37% topline growth

GSFC Q4 Results: Higher expenses weigh on margins, profitability despite 37% topline growth

Shares of Gujarat State Fertilizers & Chemicals Ltd. (GSFC) fell more than 3% after the company reported a sharp year-on-year drop in the March quarter profit, despite strong revenue growth. Higher expenses impacted the bottomline during the quarter. The company reported consolidated net profit of ₹52.1 crore for Q4FY26, down 27.5% from ₹71.7 crore in…

Read More
Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%

Jubilant Pharmova Q4 profit declines on margin pressure; revenue rises 19%

Jubilant Pharmova Ltd reported a mixed set of fourth-quarter earnings for FY26, with strong topline growth offset by margin pressure that weighed on profitability during the quarter. The company posted a 23% year-on-year decline in consolidated net profit at ₹119 crore for the March quarter, compared with ₹154 crore in the corresponding period last year….

Read More
Dilip Buildcon wins ₹268 crore order from Gujarat govt for Sabarmati barrage project

Dilip Buildcon JV receives ₹268 crore EPC order for Sabarmati river works in Gujarat

Multi-asset infrastructure developer Dilip Buildcon Ltd (DBL) on Friday (May 22) said the company, through its DBL-RBL (Ranjit Buildcon Ltd) joint venture, has received a letter of award (LOA) worth ₹268 crore (excluding GST) for an EPC project in Gujarat. The order has been awarded by the Narmada Water Resources, Water Supply & Kalpasar department,…

Read More
Lupin arm to acquire 43.38% stake in Multicare Pharmaceuticals Philippines for US $39.6 m

Lupin gets approval to launch flu medicine in China, enters Chinese market for first time

Global pharmaceutical major Lupin Limited on Friday announced that China’s National Medical Products Administration has approved its Abbreviated New Drug Application for Oseltamivir Phosphate for oral suspension, developed in partnership with Yabao Pharmaceuticals. The approval marks Lupin’s first product entry into the Chinese market, representing a development in the company’s global expansion plans. Oseltamivir Phosphate…

Read More
Minda Corporation Q4 net profit jumps over 2x as revenue hits record ₹1,704 crore

Minda Corporation Q4 net profit jumps over 2x as revenue hits record ₹1,704 crore

Auto components maker Minda Corporation Ltd on Friday (May 22) reported a consolidated net profit of ₹125 crore for the fourth quarter of FY26, up about 140% from ₹52 crore in the corresponding quarter last year. It achieved its highest-ever quarterly revenue of ₹1,704 crore, up 29% year-on-year from ₹1,321.3 crore, surpassing industry growth and…

Read More
Colgate beats sales estimates in Q4, announces ₹24 dividend

Colgate beats sales estimates in Q4, announces ₹24 dividend

Colgate-Palmolive (India) Limitedreported fourth-quarter earnings with revenue and EBITDA surpassing CNBC-TV18 poll estimates, while net profit came in marginally below expectations. The company posted a net profit of ₹353.3 crore for the quarter, slightly below the CNBC-TV18 estimate of ₹357 crore. Profit declined 0.5% year-on-year from ₹355 crore in the corresponding quarter last year. Revenue…

Read More